GE HealthCare (GEHC) CFO William Grogan Receives Equity Awards

What Happened

• William K. Grogan, Chief Financial Officer of GE HealthCare Technologies Inc. (GEHC), received equity awards on September 14, 2026. The filing reports grants of 62,256 RSUs, 12,840 RSUs, and 31,877 stock options. All awards reported a transaction price of $0.00 (i.e., they were compensation grants, not purchases), and no cash changed hands on grant.

Key Details

• Transaction date: 2026-09-14 (filed on 2026-09-16; filing appears timely under Form 4 rules).
• Awards:
  • 62,256 restricted stock units (RSUs) — 50% vest on 2027-09-14 and 50% vest on 2028-09-14. (Footnote F1)
  • 12,840 RSUs — vest 33% on 2027-09-02, 33% on 2028-09-02, and 34% on 2029-09-02. (Footnote F3)
  • 31,877 employee stock options (derivative) — become exercisable 33% on 2027-09-02, 33% on 2028-09-02, and 34% on 2029-09-02. (Footnote F4)
• Each RSU represents the right to receive one share at settlement. (Footnote F2)
• Filing timeliness: Transaction reported for 9/14/2026 and Form 4 filed 9/16/2026 — no late‑filing flag indicated in the provided excerpt.
• Shares owned after the transaction are not specified in the provided excerpt.

Context

• RSUs: these convert to actual shares upon vesting/settlement; they are compensation rather than open‑market purchases or sales.
• Options: vest according to the schedule above and must be exercised to result in shares; this grant was an award (not an exercise or sale).
• Such awards are standard executive compensation and do not, by themselves, signal a buy or sell decision by the insider.